Therapeutic Antibodies
-
-
The CPRIT Therapeutic Antibody Core
We offer Texas-wide access to specialized technical expertise, instrumentation, and automation to advance lead antibodies with “drug like” properties from academic laboratories to the stage of preclinical development.
-
Therapeutic Antibody Development
Lead Identification – Lead Optimization – Lead Construction – Antibody Production
New antibody therapies found to potentially fight COVID-19
January 21, 2021 | Jeannette Sanchez
Researchers at The University of Texas Health Science Center at Houston (UTHealth) and The University of Texas Medical Branch at Galveston (UTMB Health) have discovered a potential new antibody therapy for COVID-19. The study was published in Nature Communications.
The first virtual Symposium of the CPRIT Therapeutic Antibody Core
December 11, 2020
The annual symposium of the CPRIT Therapeutic Antibody Core took place on Friday, December 11, 2020, from 1:00 pm Central Time. For the safety of participants during the COVID-19 pandemic, the symposium was held online via WebEx. Speakers highlighted the core’s capacities and provided examples of successful core collaborations.
The 2019 Annual Symposium of the CPRIT Therapeutic Antibody Core
February 26, 2020
The annual symposium of the CPRIT Therapeutic Antibody Core took place on Tuesday, December 10, 2019, at the University of Texas Health Science Center at Houston (UTHealth – Houston). Speakers highlighted the core’s capacities and provided examples of successful core collaborations.
